for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CVS Health Corp

CVS.N

Latest Trade

55.72USD

Change

0.31(+0.56%)

Volume

1,695,141

Today's Range

54.37

 - 

56.60

52 Week Range

51.72

 - 

77.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
55.41
Open
55.22
Volume
1,695,141
3M AVG Volume
230.28
Today's High
56.60
Today's Low
54.37
52 Week High
77.00
52 Week Low
51.72
Shares Out (MIL)
1,304.16
Market Cap (MIL)
72,667.78
Forward P/E
--
Dividend (Yield %)
3.59

Next Event

Dividend For CVS.N - 0.5000 USD

Latest Developments

More

CVS Health Says Cannot Reasonably Estimate Adverse Impact COVID-19 Will Have On Businesses, Operating Results, Cash Flows &/Or Financial Condition

CVS Health Says Moving To Protect Supply Of Medicines Potentially Useful For COVID-19 Treatment

Cvs Health Sets Quarterly Dividend Of $0.50Per Share

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CVS Health Corp

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Contact Info

1 Cvs Dr

WOONSOCKET, RI

02895-6146

United States

+1.401.7651500

https://www.cvshealth.com/

Executive Leadership

David W. Dorman

Independent Chairman of the Board

Larry J. Merlo

President, Chief Executive Officer, Director

Eva C. Boratto

Chief Financial Officer, Executive Vice President

Jonathan C. Roberts

Chief Operating Officer, Executive Vice President

Lisa G. Bisaccia

Chief Human Resource Officer, Executive Vice President

Key Stats

2.11 mean rating - 27 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

184.8K

2018

194.6K

2019

256.8K

2020(E)

263.3K
EPS (USD)

2017

5.900

2018

7.080

2019

7.080

2020(E)

7.116
Price To Earnings (TTM)
10.96
Price To Sales (TTM)
0.28
Price To Book (MRQ)
1.14
Price To Cash Flow (TTM)
6.61
Total Debt To Equity (MRQ)
107.23
LT Debt To Equity (MRQ)
101.31
Return on Investment (TTM)
4.13
Return on Equity (TTM)
3.17

Latest News

Latest News

BRIEF-CVS Health CEO's 2019 Total Compensation Was $36.5 Million

* CVS HEALTH CORP - CEO LARRY J. MERLO'S 2019 TOTAL COMPENSATION WAS $36.5 MILLION VERSUS $21.9 MILLION IN 2018 - SEC FILING

BRIEF-CVS Health Files For $4 Bln Four-Part Senior Notes Offering

* CVS HEALTH FILES FOR $4 BILLION FOUR-PART SENIOR NOTES OFFERING - SEC FILING

CVS says membership, payment collection hit by coronavirus

U.S. drugstore operator CVS Health Corp <CVS.N> said on Thursday its medical membership and payment collection have been hit due to the coronavirus pandemic, although it cannot reasonably estimate the impact on its businesses, cash flows or operating results.

BRIEF-CVS Health Says Cannot Reasonably Estimate Adverse Impact COVID-19 Will Have On Businesses, Operating Results, Cash Flows &/Or Financial Condition

* CVS HEALTH - AT THIS TIME, CANNOT REASONABLY ESTIMATE ADVERSE IMPACT COVID-19 WILL HAVE ON BUSINESSES, OPERATING RESULTS, CASH FLOWS &/OR FINANCIAL CONDITION

BRIEF-CVS Health Says Moving To Protect Supply Of Medicines Potentially Useful For COVID-19 Treatment

* CVS - THE MEDICINES INCLUDE HYDROXYCHLOROQUINE, AZITHROMYCIN, ONE PROTEASE INHIBITOR AND ALBUTEROL INHALERS

BRIEF-CVS Health Announces Cost-Sharing And Co-Pay Waivers For COVID-19-Related Treatment For Aetna Members

* CVS HEALTH ANNOUNCES COST-SHARING AND CO-PAY WAIVERS FOR COVID-19-RELATED TREATMENT FOR AETNA MEMBERS

CVS moves to prevent stockpiling of malaria drug amid coronavirus

CVS Health said on Wednesday its pharmacy benefit management (PBM) unit was laying out measures to prevent the stockpiling of malaria drug, hydroxychloroquine, which is being tested as a potential treatment for the coronavirus.

BRIEF-CVS Health To Provide Bonuses, Add Benefits And Hire 50,000 In Response To Pandemic

* CVS HEALTH TO PROVIDE BONUSES, ADD BENEFITS AND HIRE 50,000 IN RESPONSE TO PANDEMIC Source text for Eikon: Further company coverage:

CVS to hire 50,000 employees for coronavirus assistance

Drugstore chain CVS Health Corp said on Monday it was hiring 50,000 employees across the United States to assist patients and customers with the coronavirus outbreak.

CVS announces first drive-thru coronavirus testing site in Massachusetts

CVS Health Corp said on Thursday it is opening a COVID-19 testing site for a limited population in the parking lot of a CVS Pharmacy in Shrewsbury, Massachusetts.

BRIEF-Livongo Expands Relationship With CVS Health

* LIVONGO EXPANDS RELATIONSHIP WITH CVS HEALTH, NOW PART OF CHRONIC CONDITION MANAGEMENT PLATFORM WITHIN POINT SOLUTIONS SERVICE

BRIEF-Cvs Health Sets Quarterly Dividend Of $0.50Per Share

* SETS QUARTERLY DIVIDEND OF $0.50PER SHARE Source text for Eikon: Further company coverage:

CVS Health offers free home delivery of prescription drugs amid virus outbreak

CVS Health Corp said on Monday it would immediately waive charges for home delivery of prescription medications, in response to the U.S. health agencies urging patients to stay at home amid a fast-spreading coronavirus outbreak.

BRIEF-CVS Health Announces Additional Covid-19 Resources Focused On Patient Access

* CVS HEALTH ANNOUNCES ADDITIONAL COVID-19 RESOURCES FOCUSED ON PATIENT ACCESS

BRIEF-Cvs Health Announces Covid-19 Resources For Aetna Members

* CVS HEALTH - PROVIDING COVID-19 DIAGNOSTIC TESTING & TELEMEDICINE VISITS WITH NO OUT-OF-POCKET COSTS OR COST SHARING FOR AETNA MEMBERS

Ex-CVS executive loses appeal to join Amazon's PillPack

A federal appeals court on Friday barred a former executive at CVS Health's pharmacy benefit manager division from working at an Amazon.com Inc online pharmacy unit that aims to disrupt the healthcare industry.

CVS profit beats estimates; will hold off on new major deals

CVS Health Corp reported a higher-than-expected fourth-quarter profit on Wednesday as its stores sold more medicines and the pharmacy benefit management (PBM) business benefited from higher U.S. prescription drug prices.

BRIEF-CVS Health Announces Changes To Support Innovation And Growth

* CVS HEALTH ANNOUNCES CHANGES TO SUPPORT INNOVATION AND GROWTH

BRIEF-CVS Health Reports Fourth Quarter And Full-Year 2019 Results

* CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2019 RESULTS, REFLECTING STRONG EXECUTION ACROSS THE ENTERPRISE

CVS Health posts fourth-quarter profit

CVS Health Corp on Wednesday reported a quarterly profit compared with a year-ago loss, which included a $2.2 billion charge, with the latest quarter benefiting from its Aetna health insurance business.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up